EVENTS
2024/07/05
第51回日本毒性学会学術年会
2024/05/14
2024年2月14日（水）における次世代ゼブラフィッシュ創薬・研究開発セミナー
2024/05/08
第51回日本毒性学会ゼブラフィッシュ腎毒性スクリーニング
2024/05/02
ゼブラフィッシュ毒性研究における飼育品質管理の重要性
》discovery of stanniocalcin1 as cardiotoxic defence gene
2024/04/25
We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.